Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 160-160
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
Divya Teli, Pankti C. Balar, Kishan Patel, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 25
Evolution and implications of SARS-CoV-2 variants in the post-pandemic era
Emery Manirambona, Olalekan John Okesanya, Noah Olabode Olaleke, et al.
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Phytoestrogens: Chemistry, potential health benefits, and their medicinal importance
Vivek P. Chavda, Amit Z. Chaudhari, Pankti C. Balar, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3060-3079
Open Access | Times Cited: 7
Conventional vaccination methods: Inactivated and live attenuated vaccines
Terrick Andey, Shailvi Soni, Shail Modi
Elsevier eBooks (2024), pp. 37-50
Closed Access | Times Cited: 5
Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 507-507
Open Access | Times Cited: 13
Regulatory processes involved in clinical trials and intellectual property rights around vaccine development
Nimeet Desai, Shreya Pande, Amol D. Gholap, et al.
Elsevier eBooks (2024), pp. 279-309
Closed Access | Times Cited: 4
Vaccine safety, efficacy, and ethical considerations
Rashi K. Shukla, Krupa Vyas, Avinash Khadela, et al.
Elsevier eBooks (2024), pp. 311-324
Closed Access | Times Cited: 2
A SARS-CoV-2: Companion Animal Transmission and Variants Classification
Rachana Pandit, Qiana L. Matthews
Pathogens (2023) Vol. 12, Iss. 6, pp. 775-775
Open Access | Times Cited: 7
The potential role of essential oils in boosting immunity and easing COVID-19 symptoms
Vivek P. Chavda, Pankti C. Balar, Gargi Jogi, et al.
Deleted Journal (2024) Vol. 5, Iss. 1, pp. 200135-200135
Open Access | Times Cited: 1
Proteogenomics and immunopeptidomics in the development of advanced vaccines
Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, et al.
Elsevier eBooks (2024), pp. 455-475
Closed Access | Times Cited: 1
History of vaccination
Vivek P. Chavda, Pankti C. Balar, Vasso Apostolopoulos
Elsevier eBooks (2024), pp. 1-12
Closed Access | Times Cited: 1
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
Dona Susan Mathew, T. Pandya, HC Pandya, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 4
Identification of conserved immunogenic peptides of SARS-CoV-2 nucleocapsid protein
Jigyasa Verma, Neha Kaushal, Manish Manish, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 20, pp. 11098-11114
Closed Access | Times Cited: 3
Vector-based vaccine delivery and associated immunity
Mohsen Akbarian, Lobat Tayebi, Elrashdy M. Redwan, et al.
Elsevier eBooks (2024), pp. 73-98
Closed Access
Phylogenetic analysis of Omicron subvariants in Vietnam
Phuoc Huynh, Huyen Thi Thuong Nguyen, Quan Ke Thai
Journal of Applied Biology & Biotechnology (2024)
Open Access
Role of prior immunity in binding to spike of “future” Omicron subvariants
Deepayan Biswas, Gokulnath Mahalingam, Rajesh Kumar Subaschandrabose, et al.
Indian Journal of Medical Microbiology (2024) Vol. 50, pp. 100615-100615
Open Access
Inter-variant Recombination, Genomic Perspectives and Pathogenicity of Emerging Sub-variants of Omicron: Recent Updates and Challenges
Gourab Das, Rubai Ahmed, Jhimli Banerjee, et al.
Gene Expression (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
Dengue virus (DV) non-cross-reactive Omicron wave COVID-19 serums enhanced DV3 infectivity in vitro
Shourav Kumar Sarker, Chiroshri Dutta, Abinash Mallick, et al.
Journal of Medical Microbiology (2024) Vol. 73, Iss. 7
Closed Access
Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
Indrani Das Jana, Kawkab Kanjo, Subhanita Roy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Dynamic Trends and Predictive Modelling of Stock Market Indices: A Comprehensive Analysis of S&P Bse Oil & Gas Index and Sensex Over 2020-2023
Sohom Majumder, Uttiya Kar, Vivekananda Biswas
(2024)
Closed Access
Global South Sisterhood in a Virtual Exchange
Bhavika Sicka, Arzu Atajanova
Journal of Comparative & International Higher Education (2024) Vol. 16, Iss. 5
Open Access
COVID-19 outbreaks caused by different SARS-CoV-2 variants: a descriptive, comparative study from China
Cao Chen, Yenan Feng, Zeyuan Yin, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Equivalent Binding Of Sera From Omicron And Delta Period To Future Omicron Subvariants
Deepayan Biswas, Gokulnath Mahalingam, Rajesh Kumar Subaschandrabose, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Pre-dominance of dengue non-cross-reacting SARS-CoV-2 spike antibodies during the Omicron era and their role in the ADE-mediated surge of Dengue virus serotype 3
Shourav Kumar Sarker, Chiroshri Dutta, Abinash Mallick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Omicron Variant Could be an Antigenic Shift of SARS-CoV-2
Anju Kaushal
(2023)
Open Access
Page 1 - Next Page

Scroll to top